Featured Research

from universities, journals, and other organizations

Is Anthrax Just The Beginning?

Date:
October 19, 2001
Source:
Northeastern University
Summary:
Jim Matthews, an associate professor of pharmacy at Northeastern University’s Bouvé College of Health Sciences, says that though the use of anthrax as a bioterrorist weapon is haunting, it is not nearly as frightening as the threat of attacks using smallpox or the bubonic plague.

What could be deadlier than anthrax? Try smallpox and the bubonic plague.

Jim Matthews, an associate professor of pharmacy at Northeastern University’s Bouvé College of Health Sciences, says that though the use of anthrax as a bioterrorist weapon is haunting, it is not nearly as frightening as the threat of attacks using smallpox or the bubonic plague.

“Anthrax is not easily transferred, so to develop it as a weapon is difficult, and in most cases, it responds quite well to antibiotics,” said Matthews. “However, what I would be more fearful and weary of is an outbreak of smallpox or the bubonic plague, caused by terrorist acts. Smallpox, for example, is contagious and there is no effective treatment available. Even as we speak, some federal officials have reason to believe that Iraq is developing it as a biological weapon.”

While Matthews believes that it is important for government to focus its energies on investigating the recent bioterrorist mailings and ensuring the availability of anthrax antibiotics and vaccines, he believes it is imperative that government accelerates work on protection against untreatable viruses.

“It’s great that federal officials are working to have the anthrax antibiotic, Ciprofloxacin readily available for those believed to be infected,” said Matthews. (“Incidentally the only anthrax vaccine manufactured in the U.S. by Michigan-based BioPort Corporation and sponsored by the Department of Defense, is only available through the Center for Disease Control and to members of the military.”)

“However, contingency plans should be in the works to guard against other bioterrorist threats such as smallpox,” warns Matthews.


Story Source:

The above story is based on materials provided by Northeastern University. Note: Materials may be edited for content and length.


Cite This Page:

Northeastern University. "Is Anthrax Just The Beginning?." ScienceDaily. ScienceDaily, 19 October 2001. <www.sciencedaily.com/releases/2001/10/011019074315.htm>.
Northeastern University. (2001, October 19). Is Anthrax Just The Beginning?. ScienceDaily. Retrieved August 22, 2014 from www.sciencedaily.com/releases/2001/10/011019074315.htm
Northeastern University. "Is Anthrax Just The Beginning?." ScienceDaily. www.sciencedaily.com/releases/2001/10/011019074315.htm (accessed August 22, 2014).

Share This




More Health & Medicine News

Friday, August 22, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Drug Used To Treat 'Ebola's Cousin' Shows Promise

Drug Used To Treat 'Ebola's Cousin' Shows Promise

Newsy (Aug. 21, 2014) — An experimental drug used to treat Marburg virus in rhesus monkeys could give new insight into a similar treatment for Ebola. Video provided by Newsy
Powered by NewsLook.com
Two US Ebola Patients Leave Hospital Free of the Disease

Two US Ebola Patients Leave Hospital Free of the Disease

AFP (Aug. 21, 2014) — Two American missionaries who were sickened with Ebola while working in Liberia and were treated with an experimental drug are doing better and have left the hospital, doctors say on August 21, 2014. Duration: 01:05 Video provided by AFP
Powered by NewsLook.com
Cadavers, a Teen, and a Medical School Dream

Cadavers, a Teen, and a Medical School Dream

AP (Aug. 21, 2014) — Contains graphic content. He's only 17. But Johntrell Bowles has wanted to be a doctor from a young age, despite the odds against him. He was recently the youngest participant in a cadaver program at the Indiana University NW medical school. (Aug. 21) Video provided by AP
Powered by NewsLook.com
American Ebola Patients Released: What Cured Them?

American Ebola Patients Released: What Cured Them?

Newsy (Aug. 21, 2014) — It's unclear whether the American Ebola patients' recoveries can be attributed to an experimental drug or early detection and good medical care. Video provided by Newsy
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
 
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:  

Breaking News:
from the past week

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:  

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile iPhone Android Web
Follow Facebook Twitter Google+
Subscribe RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins